B. J. Kumar, V. T. Mahalingam, and G. Kumar, “CYP2C19 polymorphisms on escitalopram treatment outcome in South Indian population with major depressive disorder”, ScienceRise: Pharmaceutical Science, no. 3 (49), pp. 70–77, Jun. 2024.